REVO Insurance (REVO) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Maintained high diversification across insurance portfolio, with significant growth in Iberian market and specialty lines, notably Energy and parametric solutions.
Expanded distribution network and partnerships, including a new embedded group policy with Satispay, reaching over 450,000 merchants.
Enhanced operational efficiency and underwriting quality through AI-driven innovations and 19 new hires focused on Data & Analytics and Underwriting.
Financial highlights
Insurance contract revenue rose to €79.7M, up 20.0% year-over-year; gross written premiums reached €115.8M.
Net profit increased to €7.4M, with adjusted net profit at €8.2M, both up from Q1 2025.
Adjusted operating result grew 15.2% to €13.6M compared to Q1 2025.
Net financial result was €1.6M, with €1.5M from investments; shareholders' equity at €261.4M.
Outlook and guidance
Maintains strong resilience and growth trajectory despite macroeconomic uncertainty, with continued technical quality into Q2 2026.
Latest events from REVO Insurance
- Premiums up 28.9%, adjusted net profit €28.6M, Solvency II ratio 223.2%, €0.27 dividend proposed.REVO
H2 202528 Apr 2026 - Premiums up 52.5%, net profit up 50%, with strong ratios and robust capital position.REVO
H1 202425 Jan 2026 - Premiums up 42.8%, net profit €22.6M, targets beat early, and dividend rises to €0.22.REVO
H2 20247 Jan 2026 - AI-driven plan targets €550M+ GWP, €50M+ profit, and specialty line growth by 2028.REVO
Investor Day 20256 Jan 2026 - Premiums up 31%, adjusted profit €25.8M, net profit €11.3M, Solvency II ratio 245.2%.REVO
H1 20256 Jan 2026 - Premiums up 29.4%, adjusted net profit €24.2M, and strong capital position support growth.REVO
Q3 20256 Nov 2025 - Premiums up 45.5% and adjusted net profit up 45% year-over-year, exceeding 2023 results.REVO
Q3 20247 Oct 2025 - Premiums up 40.7%, adjusted operating profit up 18.4%, Solvency II ratio at 246.6%.REVO
Q1 20257 Oct 2025